[Reirradiation for head and neck squamous cell carcinoma: Indications and results].
Réirradiations des carcinomes épidermoïdes des voies aérodigestives supérieures : indications et résultats.
Brachytherapy
Humans
Neoplasm Recurrence, Local
/ radiotherapy
Neoplasms, Second Primary
/ radiotherapy
Patient Selection
Postoperative Care
Proton Therapy
Radiation Injuries
/ pathology
Radiosurgery
Radiotherapy, Intensity-Modulated
Randomized Controlled Trials as Topic
Re-Irradiation
/ methods
Retrospective Studies
Risk Assessment
Squamous Cell Carcinoma of Head and Neck
/ pathology
Time Factors
Cancers des voies aéro-digestives supérieures
Cancers of the upper aerodigestive tracts
Carcinomes épidermoïdes
Conformational radiotherapy with intensity modulation
IMRT
Radiothérapie stéréotaxique
Reirradiation
Réirradiation
Squamous cell carcinomas
Stereotactic radiotherapy
Journal
Cancer radiotherapie : journal de la Societe francaise de radiotherapie oncologique
ISSN: 1769-6658
Titre abrégé: Cancer Radiother
Pays: France
ID NLM: 9711272
Informations de publication
Date de publication:
Oct 2019
Oct 2019
Historique:
received:
14
06
2019
accepted:
08
07
2019
pubmed:
28
8
2019
medline:
9
10
2019
entrez:
28
8
2019
Statut:
ppublish
Résumé
Despite progress in the management of head and neck squamous cell carcinoma (HNSCC), a significant proportion of patients previously irradiated for head-and-neck cancer will develop locoregional recurrence or a second primary. Because of the heterogeneity of this population with respect to disease-related factors (localization, volume, recurrence or second primary, time interval from previous irradiation…) and patient-related factors (comorbidities, sequelae of previous irradiation…), the optimal reirradiation treatment remains to be defined. Salvage therapy using reirradiation, despite some encouraging results, has historically been avoided because of concerns regarding toxicity. The results of more recent studies using contemporary treatment techniques and conformal delivery methods such as intensity modulated radiation therapy (IMRT) or stereotactic radiotherapy (SBRT) have been somewhat more promising. The aim of this review is to discuss the reirradiation of HNSCC in terms of patient selection and modern radiotherapy techniques.
Identifiants
pubmed: 31451359
pii: S1278-3218(19)30323-3
doi: 10.1016/j.canrad.2019.07.147
pii:
doi:
Types de publication
Journal Article
Review
Langues
fre
Sous-ensembles de citation
IM
Pagination
559-564Informations de copyright
Copyright © 2019 Société française de radiothérapie oncologique (SFRO). Published by Elsevier Masson SAS. All rights reserved.